Bartberger; Michael D.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bartberger; Michael D..The latest application filed is for "kras g12c inhibitors and uses thereof".
Company Profile
7.17.26
- Bartberger; Michael D. - Sherman Oaks CA
- Bartberger; Michael D. - Thousand Oaks CA
Patent Activity
| Patent | Date |
|---|---|
| CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer Grant 11,407,721 - Bartberger , et al. August 9, 2 | 2022-08-09 |
| Kras G12c Inhibitors And Uses Thereof App 20220227738 - Hilf; Justin A. ; et al. | 2022-07-21 |
| Prmt5 Inhibitors And Uses Thereof App 20220194949 - O'Boyle; Brendan M. ; et al. | 2022-06-23 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20220169611 - Bartberger; Michael D. ; et al. | 2022-06-02 |
| Benzimidazole derivatives and their uses Grant 11,332,459 - Bartberger , et al. May 17, 2 | 2022-05-17 |
| Cdk Inhibitors And Uses Thereof App 20220106325 - O'Boyle; Brendan M. ; et al. | 2022-04-07 |
| Erk Inhibitors And Uses Thereof App 20220002294 - Reeves; Corey M. ; et al. | 2022-01-06 |
| KRAS G12C inhibitors and methods of using the same Grant 11,096,939 - Booker , et al. August 24, 2 | 2021-08-24 |
| KRAS G12C inhibitors and methods of using the same Grant 11,045,484 - Wurz , et al. June 29, 2 | 2021-06-29 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20210179560 - Bartberger; Michael D. ; et al. | 2021-06-17 |
| KRAS G12C inhibitors and methods of using the same Grant 10,988,485 - Minatti , et al. April 27, 2 | 2021-04-27 |
| Benzimidazole Derivatives And Their Uses App 20200308145 - BARTBERGER; Michael D. ; et al. | 2020-10-01 |
| Kras G12c Inhibitors And Methods Of Using The Same App 20200030324 - BOOKER; Shon ; et al. | 2020-01-30 |
| Kras G12c Inhibitors And Methods Of Using The Same App 20190345169 - MINATTI; Ana Elena ; et al. | 2019-11-14 |
| Kras G12c Inhibitors And Methods Of Using The Same App 20190336514 - WURZ; Ryan Paul ; et al. | 2019-11-07 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20190062276 - Bartberger; Michael D. ; et al. | 2019-02-28 |
| Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20180354918 - BARTBERGER; Michael D. ; et al. | 2018-12-13 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20170144971 - BARTBERGER; Michael D. ; et al. | 2017-05-25 |
| Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,593,129 - Bartberger , et al. March 14, 2 | 2017-03-14 |
| Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer Grant 9,376,425 - Bartberger , et al. June 28, 2 | 2016-06-28 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20160137667 - BARTBERGER; Michael D. ; et al. | 2016-05-19 |
| Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,296,736 - Bartberger , et al. March 29, 2 | 2016-03-29 |
| Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20160002185 - BARTBERGER; Michael D. ; et al. | 2016-01-07 |
| Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140315895 - Bartberger; Michael D. ; et al. | 2014-10-23 |
| Heterocyclic Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20140235629 - Bartberger; Michael D. ; et al. | 2014-08-21 |
| Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 8,686,011 - Henriksson , et al. April 1, 2 | 2014-04-01 |
| Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 Grant 8,541,592 - Henriksson , et al. September 24, 2 | 2013-09-24 |
| Inhibitors Of 11-beta-hydroxy Steroid Dehydrogenase Type 1 App 20120010256 - HENRIKSSON; Martin ; et al. | 2012-01-12 |
| Beta-Secretase modulators and methods of use Grant 7,973,047 - Zhong , et al. July 5, 2 | 2011-07-05 |
| Inhibitors Of 11-beta-hydroxy Steroid Dehydrogenase Type 1 App 20110082107 - Henriksson; Martin ; et al. | 2011-04-07 |
| Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 7,807,700 - Henriksson , et al. October 5, 2 | 2010-10-05 |
| Beta-secretase Modulators And Methods Of Use App 20100222338 - Zhong; Wenge ; et al. | 2010-09-02 |
| Beta-secretase modulators and methods of use Grant 7,745,484 - Zhong , et al. June 29, 2 | 2010-06-29 |
| Substituted azole aromatic heterocycles as inhibitors of 11.beta.-HSD-1 Grant 7,666,888 - Bartberger , et al. February 23, 2 | 2010-02-23 |
| Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20080045503 - Henriksson; Martin ; et al. | 2008-02-21 |
| Substituted Azole Aromatic Heterocycles As Inhibitors Of 11beta-hsd-1 App 20080021022 - Bartberger; Michael D. ; et al. | 2008-01-24 |
| Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1 App 20070281938 - Henriksson; Martin ; et al. | 2007-12-06 |
| Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20070197598 - Henriksson; Martin ; et al. | 2007-08-23 |
| Beta-secretase modulators and methods of use App 20070185144 - Zhong; Wenge ; et al. | 2007-08-09 |
| Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 7,253,196 - Henriksson , et al. August 7, 2 | 2007-08-07 |
| Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20060142357 - Henriksson; Martin ; et al. | 2006-06-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 